Aspectbiosystems
2 known investors
Aspect Bio Systems develops bioprinted tissue therapeutics for regenerative medicine using a platform that combines AI-powered bioprinting, computational design, therapeutic cells, and biomaterials. The company targets metabolic and endocrine diseases by creating implantable tissues for replacement, repair, or supplementation of biological functions.
AI & Machine LearningBiotechDeep Tech